Clinical implementation of preemptive pharmacogenomics in psychiatryΜαρία Σκώκου, Athanassios Vozikis, George P. Patrinos et al.|EBioMedicine|2024Cited by 56
Leukocyte telomere length is reduced in patients with major depressive disorderClaudia Pisanu, Alessio Squassina, Evangelia Eirini Tsermpini et al.|Drug Development Research|2019Cited by 25
Genetic Variations Associated with Sleep Disorders in Patients with Schizophrenia: A Systematic ReviewKonstantinos Assimakopoulos, Evangelia Eirini Tsermpini, Katerina Karaivazoglou et al.|Medicines|2018Cited by 19
Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics dataZoe Kordou, Maria Koromina, Μαρία Σκώκου et al.|Pharmacological Research|2021Cited by 10
Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe “PREPARE” studyEvangelia Eirini Tsermpini, GP Patrinos, Μαρία Σκώκου et al.|Psychiatriki|2020Cited by 9